FES Antikörper (AA 510-770)

Produktnummer ABIN5013541

Produktdetails anti-FES Antikörper

Target: FES (Feline Sarcoma Oncogene (FES))

Bindungsspezifität: AA 510-770

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FES Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Spezifität: The antibody is a rabbit polyclonal antibody raised against FES. It has been selected for its ability to recognize FES in immunohistochemical staining and western blotting.

Aufreinigung: Antigen-specific affinity chromatography

Immunogen: FES (Asp510-Arg770)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

• Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Details zu FES

Target: FES (Feline Sarcoma Oncogene (FES))

Abstract: FES Produkte

Synonyme: FPS antikoerper, RGD1564385 antikoerper, AI586313 antikoerper, BB137047 antikoerper, c-fes antikoerper, FES antikoerper, c-fps antikoerper, FES proto-oncogene, tyrosine kinase antikoerper, feline sarcoma oncogene antikoerper, FES antikoerper, Fes antikoerper, fes antikoerper

Hintergrund: Alternative Names: FPS, Oncogene FES,Feline Sarcoma Virus, c-Fes/Fps Protein, Feline sarcoma/Fujinami avian sarcoma oncogene homolog

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Signaling Events mediated by VEGFR1 and VEGFR2